Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 10, 2013, Pages

  Manning, Janet R ^a   Perkins, Sarah O ^b   Sinclair, Elizabeth A ^b   Gao, Xiaoqian ^a   Zhang, Yu ^a   Newman, Gilbert ^a   Pyle, W Glen ^b   Schultz, Jo El J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Actomyosin ATPase; Low molecular weight FGF2; PKC and ; Postischemic cardiac function; Troponin

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LACTATE DEHYDROGENASE; MUSCLE PROTEIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; TROPONIN I; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOBLOTTING; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTOMYOSIN ATPASE; LOW MOLECULAR WEIGHT FGF2; PKCΑ AND Ε; POSTISCHEMIC CARDIAC FUNCTION; TROPONIN;

ACTOMYOSIN; ANIMALS; BLOTTING, WESTERN; CA(2+) MG(2+)-ATPASE; FEMALE; FIBROBLAST GROWTH FACTOR 2; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, KNOCKOUT; MOLECULAR WEIGHT; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOFIBRILS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, FIBROBLAST GROWTH FACTOR; TROPONIN I; TROPONIN T;

EID: 84878561443     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00613.2012     Document Type: Article

References (70)

1. Akita Y. Protein kinase Cepsilon: multiple roles in the function of, and signaling mediated by, the cytoskeleton. FEBS J 275: 3995-4004, 2008.
2. Avner BS, Shioura KM, Scruggs SB, Grachoff M, Geenen DL, Helseth DL Jr, Farjah M, Goldspink PH, Solaro RJ. Myocardial infarction in mice alters sarcomeric function via post-translational protein modification. Mol Cell Biochem 363: 203-215, 2012.
3. Azhar M, Yin M, Zhou M, Li H, Mustafa M, Nusayr E, Keenan JB, Chen H, Pawlosky S, Gard C, Grisham C, Sanford LP, Doetschman T. Gene targeted ablation of high molecular weight fibroblast growth factor-2. Dev Dyn 238: 351-357, 2009.
4. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293: H1883-H1891, 2007.
5. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, de Tombe PP. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res 101: 195-204, 2007.
6. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 18: 26-45, 1997.
7. Bolli R. Why myocardial stunning is clinically important. Basic Res Cardiol 93: 169-172, 1998.
8. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999.
9. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004.
10. Budas GR, Churchill EN, Mochly-Rosen D. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol Res 55: 523-536, 2007.
11. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, Solaro RJ. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 278: 11265-11272, 2003.
12. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F, Pepe S. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 57: 300-309, 2011.
13. Chen CH, Gray MO, Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci USA 96: 12784-12789, 1999.
14. Churchill EN, Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 35: 1040-1042, 2007.
15. Czuriga D, Toth A, Pasztor ET, Balogh A, Bodnar A, Nizsaloczki E, Lionetti V, Recchia FA, Czuriga I, Edes I, Papp Z. Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacinginduced heart failure. Basic Res Cardiol 107: 244, 2012.
16. Das A, Ockaili R, Salloum F, Kukreja RC. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am J Physiol Heart Circ Physiol 286: H1455-H1460, 2004.
17. Disatnik MH, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res 210: 287-297, 1994.
18. Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D. Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6: 1195-1202, 1991.
19. Engel PL, Hinken A, Solaro RJ. Differential effects of phosphorylation of regions of troponin I in modifying cooperative activation of cardiac thin filaments. J Mol Cell Cardiol 47: 359-364, 2009.
20. Florkiewicz RZ, Baird A, Gonzalez AM. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4: 265-275, 1991.
21. Fryer RM, Wang Y, Hsu AK, Gross GJ. Essential activation of PKC-δ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353, 2001.
22. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, Solaro RJ, Buttrick PM. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 95: 424-432, 2004.
23. Hassouna A, Matata BM, Galinanes M. PKC-PPis upstream and PKC-δ is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 287: C1418-C1425, 2004.
24. Heusch G, Schulz R. A radical view on the contractile machinery in human heart failure. J Am Coll Cardiol 57: 310-312, 2011.
25. Hoffman JW Jr, Gilbert TB, Poston RS, Silldorff EP. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J Extra Corpor Technol 36: 391-411, 2004.
26. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz Jel J. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 108: 3140-3148, 2003.
27. House SL, Melhorn SJ, Newman G, Doetschman T, Schultz JE. The protein kinase C pathway mediates cardioprotection induced by cardiacspecific overexpression of fibroblast growth factor-2. Am J Physiol Heart Circ Physiol 293: H354-H365, 2007.
28. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 111: 44-50, 2005.
29. Inagaki K, Hahn HS, Dorn GW 2nd, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108: 869-875, 2003.
30. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, Cattini PA, Dixon IM, Kardami E. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol 282: H1071-H1080, 2002.
31. Jiang ZS, Wen GB, Tang ZH, Srisakuldee W, Fandrich RR, Kardami E. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases [corrected]. Can J Physiol Pharmacol 87: 798-804, 2009.
32. Kaneda K, Miyamae M, Sugioka S, Okusa C, Inamura Y, Domae N, Kotani J, Figueredo VM. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts. Anesth Analg 106: 9-16, table of contents, 2008.
33. Kim HJ, Kim JH, Bae SC, Choi JY, Ryoo HM. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278: 319-326, 2003.
34. 2+ sensitivity in human myocardium. Basic Res Cardiol 105: 289-300, 2010.
35. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693-702, 1997.
36. Kudo M, Wang Y, Xu M, Ayub A, Ashraf M. Adenosine A1 receptor mediates late preconditioning via activation of PKC-δ signaling pathway. Am J Physiol Heart Circ Physiol 283: H296-H301, 2002.
37. Landau C, Jacobs AK, Haudenschild CC. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 129: 924-931, 1995.
38. Li MX, Wang X, Lindhout DA, Buscemi N, Van Eyk JE, Sykes BD. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry 42: 14460-14468, 2003.
39. Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz Jel J. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn 238: 249-264, 2009.
40. Liao S, Bodmer JR, Azhar M, Newman G, Coffin JD, Doetschman T, Schultz Jel J. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury. J Mol Cell Cardiol 48: 1245-1254, 2010.
41. Liao S, Porter D, Scott A, Newman G, Doetschman T, Schultz Jel J. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. J Mol Cell Cardiol 42: 106-120, 2007.
42. Lim YP, Low BC, Lim J, Wong ES, Guy GR. Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling. J Biol Chem 274: 19025-19034, 1999.
43. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215, 2010.
44. MacGowan GA, Du C, Cowan DB, Stamm C, McGowan FX, Solaro RJ, Koretsky AP, Del Nido PJ. Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am J Physiol Heart Circ Physiol 280: H835-H843, 2001.
45. Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M, Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358: 681-684, 1992.
46. Molnar A, Borbely A, Czuriga D, Ivetta SM, Szilagyi S, Hertelendi Z, Pasztor ET, Balogh A, Galajda Z, Szerafin T, Jaquet K, Papp Z, Edes I, Toth A. Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes. J Biol Chem 284: 1031-1039, 2009.
47. Murphy S, Frishman WH. Protein kinase C in cardiac disease and as a potential therapeutic target. Cardiol Rev 13: 3-12, 2005.
48. Patton C, Thompson S, Epel D. Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium 35: 427-431, 2004.
49. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
50. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligandreceptor specificity. Cell 101: 413-424, 2000.
51. Pyle WG, Chen Y, Hofmann PA. Cardioprotection through a PKCdependent decrease in myofilament ATPase. Am J Physiol Heart Circ Physiol 285: H1220-H1228, 2003.
52. Robia SL, Ghanta J, Robu VG, Walker JW. Localization and kinetics of protein kinase C-epsilon anchoring in cardiac myocytes. Biophys J 80: 2140-2151, 2001.
53. Schreiber KL, Paquet L, Allen BG, Rindt H. Protein kinase C isoform expression and activity in the mouse heart. Am J Physiol Heart Circ Physiol 281: H2062-H2071, 2001.
54. Sheikh F, Sontag DP, Fandrich RR, Kardami E, Cattini PA. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol Heart Circ Physiol 280: H1039-H1050, 2001.
55. Shintani-Ishida K, Yoshida K. Ischemia induces phospholamban dephosphorylation via activation of calcineurin, PKC-alpha, and protein phosphatase 1, thereby inducing calcium overload in reperfusion. Biochim Biophys Acta 1812: 743-751, 2011.
56. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 40: 9-22, 1998.
57. Steinberg SF. Cardiac actions of protein kinase C isoforms. Physiology (Bethesda) 27: 130-139, 2012.
58. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev 88: 1341-1378, 2008.
59. Sumandea MP, Burkart EM, Kobayashi T, De Tombe PP, Solaro RJ. Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann NY Acad Sci 1015: 39-52, 2004.
60. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
61. Sumandea MP, Vahebi S, Sumandea CA, Garcia-Cazarin ML, Staidle J, Homsher E. Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function. Biochemistry 48: 7722-7731, 2009.
62. Takahashi Y, Takemura S, Minamiyama Y, Shibata T, Hirai H, Sasaki Y, Sakaguchi M, Suehiro S. Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway. Free Radic Res 41: 757-769, 2007.
63. Tamura K, Nakajima H, Rakue H, Sasame A, Naito Y, Nagai Y, Ibukiyama C. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 63: 357-361, 1999.
64. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol Heart Circ Physiol 266: H1588-H1595, 1994.
65. Vahlhaus C, Schulz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79: 407-414, 1996.
66. Verduyn SC, Zaremba R, van der Velden J, Stienen GJ. Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes. Basic Res Cardiol 102: 476-487, 2007.
67. Wickley PJ, Ding X, Murray PA, Damron DS. Propofol-induced activation of protein kinase C isoforms in adult rat ventricular myocytes. Anesthesiology 104: 970-977, 2006.
68. Yang F, Aiello DL, Pyle WG. Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ. Biochem Cell Biol 86: 70-78, 2008.
69. Yang FH, Pyle WG. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning. J Mol Cell Cardiol 52: 761-772, 2012.
70. Yoshida K, Kawamura S, Mizukami Y, Kitakaze M. Implication of protein kinase C-alpha, delta, and epsilon isoforms in ischemic preconditioning in perfused rat hearts. J Biochem (Tokyo) 122: 506-511, 1997.